Goldman Sachs 46th Annual Global Healthcare Conference Call June 11, 2025 3:20 PM ETCompany ParticipantsTom Cavanaugh ...

Sustained remission at 10 years was more common as well among the patients starting anti-TNFs right away, Toyoda told ...

To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...

Results from a first-in-human Phase Ia/Ib trial show that LY4170156 demonstrated a notably high overall response rate in ...

Youth Rising, a nonprofit organization, is aiming to continue being active in the Emmett community as the school year ends — ...

From seeing blockbusters to checking out local hotel pools, there's plenty to do — regardless of your budget — in the ...

Welcome to our favorite issue of the year, The Triad’s Best! As many of you may know, this is our biggest issue all year, and something we spend several months ...

Khaby Lame, the world's most popular TikTok personality with millions of followers, left the U.S. after immigration agents detained him in Las Vegas for allegedly overstaying his visa.

A talk with the author of new research suggesting that an ADC may offer practice-changing, patient-friendly treatment of ...

FORT LAUDERDALE, FL / ACCESS Newswire / June 11, 2025 / Sunshine Biopharma Inc. (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic ...

The three-year data from this trial underscore the potential of PCRX-201 to meaningfully change the treatment paradigm for patients living with osteoarthritis of the knee,” said Philip G. Conaghan, ...